Klaus H. Jensen
-
- Diabetes Treatment and Management 8
- Diabetes Management and Research 7
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 3
- Diabetes Management and Education 2
-
- Pancreatic function and diabetes 2
-
- Metabolism, Diabetes, and Cancer 3
-
- Diabetes and associated disorders 1
-
- Alzheimer's disease research and treatments 1
- Co-authors
- Toshinari AsakuraJohn B. BuseXavier Pi‐SunyerBernard ZinmanKevin D. NiswenderDavid Russell‐JonesAnders ToftGiorgio Sesti
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Klaus H. Jensen
12 papers receiving 274 citations
Peers
Comparison fields: 5 of 51
- Endocrinology, Diabetes and Metabolism 244
- Family Practice 17
- Pharmacology 52
- Endocrine and Autonomic Systems 11
- Surgery 69
Countries citing papers authored by Klaus H. Jensen
This map shows the geographic impact of Klaus H. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus H. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus H. Jensen more than expected).
Fields of papers citing papers by Klaus H. Jensen
This network shows the impact of papers produced by Klaus H. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus H. Jensen. The network helps show where Klaus H. Jensen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Klaus H. Jensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2022 | 3 | |
| 3 | 2018 | 8 | |
| 4 | 2017 | 13 | |
| 5 | 2012 | 86 | |
| 6 | 2011 | 45 | |
| 7 | Liraglutide Is Associated with Reduced Rates of Hypoglycemic Events Versus Glimepiride When Achieving Target HbA(1c) | 2010 | 1 |
| 8 | 2010 | 19 | |
| 9 | 2009 | 29 | |
| 10 | 2008 | 22 | |
| 11 | 2008 | 17 | |
| 12 | 2006 | 43 |
About Klaus H. Jensen
Klaus H. Jensen is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice and Oncology, having authored 12 papers that have together received 290 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (8 papers), Diabetes Management and Research (7 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Diabetes Management and Education (2 papers), Pancreatic function and diabetes (2 papers), Diabetes and associated disorders (1 paper) and Alzheimer's disease research and treatments (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (244 citations), Family Practice (17 citations) and Pharmacology (52 citations). Klaus H. Jensen has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Toshinari Asakura, John B. Buse, Xavier Pi‐Sunyer, Bernard Zinman, Kevin D. Niswender, David Russell‐Jones, Anders Toft, Giorgio Sesti, Hiroaki Seino and Melanie J. Davies. Their work appears in journals such as PLoS ONE, Diabetes and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.